Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab

Eur Respir J. 2006 Mar;27(3):644-6. doi: 10.1183/09031936.06.00086204.

Abstract

Lymphomatoid granulomatosis is a rare angiocentric and angiodestructive disease, which commonly involves the lungs but also the brain, kidneys, liver and skin. This report describes the case of a 33-yr-old female with an aggressive form of lymphoid granulomatosis treated with an anti-CD20 antibody. Dramatic radiological improvement was seen at the fourth week. However, the patient died at home 1 month after the last rituximab administration from a massive haemoptysis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Fatal Outcome
  • Female
  • Hemoptysis / etiology*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lymphomatoid Granulomatosis / complications*
  • Lymphomatoid Granulomatosis / drug therapy*
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab